Tag Archives: Pharmaceutical

Bloomberg Tracking Pharmaceutical Prices

One way the Trump Administration appears to attempt to control drug prices is through use of the “bully pulpit.”  Wikipedia states that the “bully pulpit”: “is a conspicuous position that provides an opportunity to speak out and be listened to. … Continue reading

Posted in International Law | Tagged , , , | Leave a comment

Court of Federal Claims Sides with Company in Bid Protest Over Interpretation of the Trade Agreements Clause in a Solicitation for a Pharmaceutical Product

By Michelle L. Butler & Alan M. Kirschenbaum — On July 10, 2018, the Court of Federal Claims found the Department of Veterans Affairs’ (“VA’s”) interpretation of the Trade Agreements clause to be arbitrary and capricious in Acetris Health, LLC … Continue reading

Posted in Products Liability | Tagged , , , , , , , , , , , , , | Leave a comment

Much-awaited US Supreme Court decision has been rendered: Animal Science Products, Inc. v. Hebei Welcome Pharmaceutical Co. Ltd.

The decision is available here and further documentation is available in the following blog: http://www.scotusblog.com/case-files/cases/animal-science-products-inc-v-hebei-welcome-pharmaceutical-co-ltd/. I would also like to refer to previous posts by fellow editors here and here. The US Supreme Court held that: “A federal court determining … Continue reading

Posted in International Law | Tagged , , , , , , , , , , , , , | Leave a comment

Disincentivizing the Use of IPRs and PGRs Against Pharmaceutical and Biologic Patents

Senator Orrin Hatch has introduced legislation designed to curb the use of IPRs and PGRs against pharmaceutical and biologic patents by essentially the denying the benefits to generic/biosimilar companies of the Hatch-Waxman Act and the Biologics Price Competition and Innovation … Continue reading

Posted in Copyright Law | Tagged , , , , , , | Leave a comment

Department of Justice Intervenes in California FCA Lawsuit Against Pharmaceutical Company

Ever since the passage of the Affordable Care Act in 2010, all violations of the Anti-Kickback Statute (AKS) have been actionable under the False Claims Act (FCA). In plain language, this means that, if you are aware that people in … Continue reading

Posted in Health Law | Tagged , , , , , , , | Leave a comment